Recent Drug Discovery Research for December 2024
Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 Topics: Drug Discovery, Renal
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Medulloblastoma (Oncology) - Drugs in Development, 2021 Topics: Drug Discovery, Pediatrics, Respiratory/Pulmonary
| Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021 Topics: Drug Discovery, CNS/Neurology, Oncology/Hematology
| Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021 Topics: Drug Discovery, Oncology/Hematology
| Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021 Topics: Drug Discovery, Oncology/Hematology
| Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021 Topics: Graves' Disease, Drug Discovery, Ophthalmology
| Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 Topics: Drug Discovery, Ophthalmology
| Retinitis Pigmentosa (Retinitis) (Ophthalmology) - Drugs in Development, 2021 Topics: Drug Discovery, Ophthalmology
| Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021 Topics: Drug Discovery, Women's Health, Men's Health, Obstetrics/Gynecology, Reproductive Health
| Colon Cancer (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Renal
| Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Toll Like Receptor 4 (hToll or CD284 or TLR4) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Overactive Bladder - Global Drug Forecast and Market Analysis to 2030 Topics: Drug Discovery, Urology
Regions: Global
| Eosinophilic Esophagitis - Opportunity Assessment and Forecast to 2030 Topics: Drug Discovery
| Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030 Topics: Drug Discovery, CNS/Neurology
Regions: Global
| Global Orphan Drugs Market Research Report 2022 Topics: Regulation & Policy, Research & Development, Drug Discovery
Regions: Global
| Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030 Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
Regions: Global
| Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery, Cardiovascular
| Left Ventricular Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Pain, Drug Discovery, CNS/Neurology
| Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery, CNS/Neurology, Gastrointestinal
Regions: Global
| Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
Regions: Global
| Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Eosinophilic Esophagitis - Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 - 2030 Topics: Drug Discovery, Clinical Trial
| Global and United States CRM197 Market Report & Forecast 2022-2028 Topics: Manufacturing, Packaging & Detailing, Drug Discovery
Regions: United States, Global
| Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030 Topics: Research & Development, Drug Discovery, Dermatology
| Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Cerebral Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Cognitive Impairment Associated With Schizophrenia (CIAS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, CNS/Neurology
| Sedation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Prescription Drugs, Drug Discovery, CNS/Neurology
| Alcohol Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, CNS/Neurology
| Otitis Media Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, Gastrointestinal
| Reflux Esophagitis (Gastroesophageal Reflux Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, Gastrointestinal
| Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Acute Renal Failure (ARF) (Acute Kidney Injury) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, Renal
| Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, Urology
| Iron Deficiency Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Blood Diseases, Drug Discovery
| Myasthenia Gravis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Bacterial Vaginosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, Obstetrics/Gynecology
|
Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|